Melanotan-1 (MT-1) na wan ultra-high-efficiency sεntetik melanosayt-stimulεt pεptida, we na sεntetik fכmyuleshכn fכ di nכchכral כmon melanocortin, we dεn gεt bכku atεnshכn na di biuti indastri. Rid Mɔ

di pεptida we dεn tכk bכt di maytochכndria SS-31, we dεn kכl bak elamipretide, na sכm mכlikul pεptida we gεt spεsifi k mitochondria-tכgεt fכnshכnaliti. insay di las ia dεm, as risεch pan di mεkanism dεm fכ ol pipul dεn de dip, di imכtant rol we di maytochכndrial dεm we de wok fayn na di ol prכsεs dεn de sho bכku bכku wan. SS-31, wit in yכnik maytochכndrial tכgεt prכpati dεm εn abiliti fכ rεgεl maytochכndrial fכnshכn, de ol prכmis fכ anti-aging aplikεshכn dεm. Rid Mɔ

Growth Hormone Deficiency (GHD) na dizכrd we de mek di gכt εn divεlכpmεnt de kכz fכ di nכ de kכmכt כ we di Growth Hormone (GH) nכ de wok fayn. GH, we na wan pεptida כmon we di antεriכr pituitary gland de kכmכt, de ple imכtant rol fכ di pikin dεm fכ gro εn divεlכpmεnt. Rid Mɔ

Fɔ lɔng tɛm naw, di wɛlbɔdi biznɛs na di say we dɛn de du risach na di say dɛn we dɛn de du mɛrɛsin ɛn layf sayɛns. Rid Mɔ

Pεptid drog dεm εn tradishכnal sכm mכlikul dεm dεn tu de ple imכtant rol fכ divεlכpmεnt fכ dכg εn klinik aplikεshכn, bכt dεn difrεn pan dεn mεkanism fכ akshכn εn aplikεshכn kכntribyushכn. Rid Mɔ

Insay di fild fɔ layf sayɛns, ol ol tɛm na wan big risach tɔpik. as risεch pan di mεkanism dεm fכ ol de kכntinyu fכ dip, di rol we nikotinamid adenine dinucleotide (NAD+) de ple fכ di anti-aging prכsεs dεn dכn gεt mכr atεnshכn. Rid Mɔ

sins dεn dכn diskovri am insay 1999, ghrelin dכn kכmכt as fכkal pכynt fכ risεch insay di layf sayns dεm bikoz fכ in yכnik fysiolojikal fכnshכn dεm εn brayt bayolojikal ifekt dεm. Rid Mɔ

We yu de du ɛksɛsayz, bɔku tɛm we yu taya, dat kin mek yu nɔ ebul fɔ bia wit ɛksesaiz. di nכmal fכnshכn fכ di enεji mεtabolism path dεm implεnt fכ mεnten di εksεsayz kapasiti. Rid Mɔ

Slu-PP-332, we na sεntetik εstrojen rεsεpכta-rεlatεd כfεn rεsεptכr (ERR) agonist, kin gεt fayn ifekt pan mכtalman hεlth insay plεnti we dεm. Rid Mɔ